Blood Group Typing Market Size & Share 2022 to 2030

Market Size by Components (Consumables, Instruments, Services), by Technique (PCR-based & Microarray, Assay-based, Next Generation Sequencing {NGS}), Test Type, End Use & Forecast.

Report ID: GMI5341

Published Date: September 2022

Report Format: PDF

Download Free PDF

Blood Group Typing Market Size

Blood Group Typing Market size surpassed USD 1.5 billion in 2021 and is expected to grow at a CAGR of over 7.5% between 2022-2030. Growing need for blood transfusion procedures and a rising number of road accidents will push the industry growth.

Blood Group Typing Market

A rise in the number of road accidents and injuries worldwide is projected to accelerate the need for blood group typing consumables and services. Excessive loss of blood is considered to be one of the major causes of death after road accidents and injuries. Globally, hemorrhagic shock has a death rate of 55.9 in every 100,000 individuals. The urgent need to undertake blood transfusion procedures in such instances will boost the demand for blood typing tests and related instruments.

Blood typing plays a crucial role in blood transfusion and donations. It is a fast and easy method used to ensure that the donor and recipient are compatible to avoid any complications. It is extremely vital in pregnant women as incompatible blood transfusion can result in agglutination or blood clumping, which is essentially fatal.

Rising incidences of Transfusion Transmitted Infections (TTIs) will propel the market revenue. TTI infections such as HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV) are an increasing concern in low-income and lower-middle-income economies.

Blood Group Typing Market Analysis

In terms of the type of components, the blood group typing market share from the instruments segment is anticipated to witness a CAGR of over 9% through 2022-2030. Instruments such as the automated blood grouping machine are used to identify the blood type of an individual by performing a wide variety of tests, such as Rh typing, cross-matching, ABO grouping, and antibody screening. With an increasing number of road accidents and trauma-inducing incidents reported worldwide, the use of blood group typing instruments is expected to soar across healthcare settings.

Blood Group Typing Market Share, By Technique

Based on the type of technique, the blood group typing market is classified into assay-based, next-generation sequencing (NGS), PCR-based & microarray, and others. PCR-based & microarray segment is projected to generate more than USD 1 billion by 2030. The process has widespread application during the screening of rare blood types. High prevalence of chronic conditions such as sickle cell anemia, and leukemia, among others, is anticipated to boost the segment outlook. The Center for Disease Control and Prevention (CDC) estimates that sickle cell anemia or sickle cell disease (SCD) affects nearly 100,000 Americans.

Blood group typing market from antigen typing segment accounted for more than 20% business share in 2021. This type of testing helps medical professionals to detect the presence or absence of corresponding antibodies in patients. The technique is often applied to individuals that need long-term transfusion therapies, helping practitioners to gain insight into the phenotypically compatible units. With the rising prevalence of infectious diseases, the application of antigen typing will gain momentum.

Blood group typing market from blood banks segment is anticipated to exceed USD 540 million by 2030. Over the last decade, the number of blood banks worldwide have increased significantly. For instance, according to the WHO, nearly 13,300 blood centers are spread across 169 countries and reported 106 million donations as of 2022. These centers are focusing on ramping up voluntary blood donations that will drive the need for blood group typing tests.

Blood Group Typing Market Size, By Region

North America blood group typing market accounted for over 30% revenue share in 2021. The U.S. has a massive footprint of key industry players who are expanding their product portfolio. The presence of federal agencies such as the Food and Drug Administration (FDA) has enabled the commercialization of innovative blood group typing solutions.

Blood Group Typing Market Share

Grifols
Ortho Clinical Diagnostics
Immucor
Quotient
BAG Diagnostics GmbH
Bio-Rad Laboratories, Inc.
Agena Bioscience
Thermo Fisher Scientific, Inc. (One Lambda, Inc.)
Danaher (Beckman Coulter Inc.)
Rapid Labs Ltd

are some of the leading companies in blood group typing industry. Development of advanced products and technological upgradation are few of the key focus areas for these firms at present.

For instance, in September 2021, Ortho Clinical Diagnostics added Immediate Spin Crossmatch (ISXM) capabilities to its comprehensive automated testing portfolio including ORTHO VISION MAX, and ORTHO VISION, which are commercially available in the U.S., Japan, and Europe. The upgrade enabled the detection of incompatibility between recipients and donors during blood transfusions.

Impact of COVID-19 Pandemic

The COVID-19 pandemic had a slightly negative impact on the blood group typing industry. In the wake of the pandemic, blood donation campaigns were suspended due to the rising concerns associated with the transmission of the virus. The industry came to a standstill after blood banks and transfusion activities slowed down considerably.

Stringent regulations and norms imposed by various public entities such as social distancing, and lockdown were major factors that further led to a drop in voluntary blood donations. For instance, in January 2022, the American Red Cross reported a dramatic blood shortage in the U.S. with a 10% reduction in the number of people donating blood since the beginning of the pandemic.

The blood group typing market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030 for the following segments:

By Components

Consumables
Instruments
Services

By Technique

PCR-based & microarray
Assay-based
Next generation sequencing (NGS)
Others

By Test Type

Antigen typing
Antibody screening & identification
ABO tests
Cross-matching tests
Others

By End-use

Hospitals
Blood banks
Laboratories
Others

The above information is provided for the following regions and countries:

North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
- Australia
Latin America
- Brazil
- Mexico
Middle East & Africa
- South Africa
- Saudi Arabia

Authors: Mariam Faizullabhoy, Gauri Wani

Blood Group Typing Market Scope

Blood Group Typing Market Size
Blood Group Typing Market Trends

Blood Group Typing Market Analysis
Blood Group Typing Market Share

Report Content

Chapter 1 Methodology & Scope

1.1 Market definitions

1.2 Base estimates & working

1.2.1 North America

1.2.2 Europe

1.2.3 Asia Pacific

1.2.4 Latin America

1.2.5 Middle East & Africa

1.3 Forecast parameters

1.4 Data validation

1.5 Data sources

1.5.1 Secondary

1.5.1.1 Paid sources

1.5.1.2 Public sources

1.5.2 Primary

Chapter 2 Executive Summary

2.1 Blood group typing industry 360⁰ synopsis, 2017 - 2030

2.1.1 Business trends

2.1.2 Components trends

2.1.3 Technique trends

2.1.4 Test type trends

2.1.5 End-use trends

2.1.6 Regional trends

Chapter 3 Blood Group Typing Industry Insights

3.1 Industry segmentation

3.2 Industry landscape, 2017 - 2030

3.3 Industry impact forces

3.3.1 Growth drivers

3.3.1.1 Growing number of road accidents, emergenices and trauma cases necessitating blood transfusion

3.3.1.2 Several blood donation campaigns undertaken by various organization

3.3.1.3 Increasing demand for blood group typing in prenatal testing

3.3.2 Industry pitfalls & challenges

3.3.2.1 Increasing prevalence of Transfusion Transmitted Infections (TTIs)

3.4 Growth potential analysis

3.4.1 By components

3.4.2 By technique

3.4.3 By test type

3.4.4 By end-use

3.5 COVID- 19 impact analysis

3.6 Regulatory landscape

3.6.1 North America

3.6.2 Europe

3.6.3 Asia Pacific

3.7 Technology landscape

3.8 Blood type compatibility landscape

3.9 Porter's analysis

3.9.1 Bargaining power of suppliers

3.9.2 Bargaining power of buyers

3.9.3 Threat of new entrants

3.9.4 Threat of substitutes

3.10 Competitive landscape, 2021

3.10.1 Global company market share analysis, 2021

3.10.2 Company matrix analysis, 2021

3.11 PESTLE analysis

3.11.1 Political

3.11.2 Economic

3.11.3 Social

3.11.4 Technological

3.11.5 Environmental

3.11.6 Legal

Chapter 4 Blood Group Typing Market, By Components

4.1 Key segment trends

4.2 Consumables

4.2.1 Market size, by region, 2017 - 2030 (USD Million)

4.3 Instruments

4.3.1 Market size, by region, 2017 - 2030 (USD Million)

4.4 Services

4.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Blood Group Typing Market, By Technique

5.1 Key segment trends

5.2 PCR-based & Microarray

5.2.1 Market size, by region, 2017 - 2030 (USD Million)

5.3 Assay-based

5.3.1 Market size, by region, 2017 - 2030 (USD Million)

5.4 Next Generation Sequencing (NGS)

5.4.1 Market size, by region, 2017 - 2030 (USD Million)

5.5 Other

5.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Blood Group Typing Market, By Test Type

6.1 Key segment trends

6.2 Antigen typing

6.2.1 Market size, by region, 2017 - 2030 (USD Million)

6.3 Anitbody screening & identification

6.3.1 Market size, by region, 2017 - 2030 (USD Million)

6.4 ABO Tests

6.4.1 Market size, by region, 2017 - 2030 (USD Million)

6.5 Cross-matching Tests

6.5.1 Market size, by region, 2017 - 2030 (USD Million)

6.6 Other

6.6.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Blood Group Typing Market, By End-use

7.1 Key segment trends

7.2 Hospitals

7.2.1 Market size, by region, 2017 - 2030 (USD Million)

7.3 Laboratories

7.3.1 Market size, by region, 2017 - 2030 (USD Million)

7.4 Blood banks

7.4.1 Market size, by region, 2017 - 2030 (USD Million)

7.5 Others

7.5.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 8 Blood Group Typing Market, By Region

8.1 Key regional trends

8.2 North America

8.2.1 Market size, by country, 2017 - 2030 (USD Million)

8.2.2 Market size, by components, 2017 - 2030 (USD Million)

8.2.3 Market size, by technique, 2017 - 2030 (USD Million)

8.2.4 Market size, by test type, 2017 - 2030 (USD Million)

8.2.5 Market size, by end-use, 2017 - 2030 (USD Million)

8.2.6 U.S.

8.2.6.1 Market size, by components, 2017 - 2030 (USD Million)

8.2.6.2 Market size, by technique, 2017 - 2030 (USD Million)

8.2.6.3 Market size, by test type, 2017 - 2030 (USD Million)

8.2.6.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.2.7 Canada

8.2.7.1 Market size, by components, 2017 - 2030 (USD Million)

8.2.7.2 Market size, by technique, 2017 - 2030 (USD Million)

8.2.7.3 Market size, by test type, 2017 - 2030 (USD Million)

8.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.3 Europe

8.3.1 Market size, by country, 2017 - 2030 (USD Million)

8.3.2 Market size, by components, 2017 - 2030 (USD Million)

8.3.3 Market size, by technique, 2017 - 2030 (USD Million)

8.3.4 Market size, by test type, 2017 - 2030 (USD Million)

8.3.5 Market size, by end-use, 2017 - 2030 (USD Million)

8.3.6 Germany

8.3.6.1 Market size, by components, 2017 - 2030 (USD Million)

8.3.6.2 Market size, by components, 2017 - 2030 (USD Million)

8.3.6.3 Market size, by test type, 2017 - 2030 (USD Million)

8.3.6.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.3.7 UK

8.3.7.1 Market size, by components, 2017 - 2030 (USD Million)

8.3.7.2 Market size, by technique, 2017 - 2030 (USD Million)

8.3.7.3 Market size, by test type, 2017 - 2030 (USD Million)

8.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.3.8 France

8.3.8.1 Market size, by components, 2017 - 2030 (USD Million)

8.3.8.2 Market size, by technique, 2017 - 2030 (USD Million)

8.3.8.3 Market size, by test type, 2017 - 2030 (USD Million)

8.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.3.9 Spain

8.3.9.1 Market size, by components, 2017 - 2030 (USD Million)

8.3.9.2 Market size, by technique, 2017 - 2030 (USD Million)

8.3.9.3 Market size, by test type, 2017 - 2030 (USD Million)

8.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.3.10 Italy

8.3.10.1 Market size, by components, 2017 - 2030 (USD Million)

8.3.10.2 Market size, by technique, 2017 - 2030 (USD Million)

8.3.10.3 Market size, by test type, 2017 - 2030 (USD Million)

8.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.4 Asia Pacific

8.4.1 Market size, by country, 2017 - 2030 (USD Million)

8.4.2 Market size, by components, 2017 - 2030 (USD Million)

8.4.3 Market size, by technique, 2017 - 2030 (USD Million)

8.4.4 Market size, by test type, 2017 - 2030 (USD Million)

8.4.5 Market size, by end-use, 2017 - 2030 (USD Million)

8.4.6 Japan

8.4.6.1 Market size, by components, 2017 - 2030 (USD Million)

8.4.6.2 Market size, by technique, 2017 - 2030 (USD Million)

8.4.6.3 Market size, by test type, 2017 - 2030 (USD Million)

8.4.6.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.4.7 China

8.4.7.1 Market size, by components, 2017 - 2030 (USD Million)

8.4.7.2 Market size, by technique, 2017 - 2030 (USD Million)

8.4.7.3 Market size, by test type, 2017 - 2030 (USD Million)

8.4.7.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.4.8 India

8.4.8.1 Market size, by components, 2017 - 2030 (USD Million)

8.4.8.2 Market size, by technique, 2017 - 2030 (USD Million)

8.4.8.3 Market size, by test type, 2017 - 2030 (USD Million)

8.4.8.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.4.9 Australia

8.4.9.1 Market size, by components, 2017 - 2030 (USD Million)

8.4.9.2 Market size, by technique, 2017 - 2030 (USD Million)

8.4.9.3 Market size, by test type, 2017 - 2030 (USD Million)

8.4.9.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.5 Latin America

8.5.1 Market size, by country, 2017 - 2030 (USD Million)

8.5.2 Market size, by components, 2017 - 2030 (USD Million)

8.5.3 Market size, by technique, 2017 - 2030 (USD Million)

8.5.4 Market size, by test type, 2017 - 2030 (USD Million)

8.5.5 Market size, by end-use, 2017 - 2030 (USD Million)

8.5.6 Brazil

8.5.6.1 Market size, by components, 2017 - 2030 (USD Million)

8.5.6.2 Market size, by technique, 2017 - 2030 (USD Million)

8.5.6.3 Market size, by test type, 2017 - 2030 (USD Million)

8.5.6.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.5.7 Mexico

8.5.7.1 Market size, by components, 2017 - 2030 (USD Million)

8.5.7.2 Market size, by technique, 2017 - 2030 (USD Million)

8.5.7.3 Market size, by test type, 2017 - 2030 (USD Million)

8.5.7.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.6 Middle East and Africa

8.6.1 Market size, by country, 2017 - 2030 (USD Million)

8.6.2 Market size, by components, 2017 - 2030 (USD Million)

8.6.3 Market size, by technique, 2017 - 2030 (USD Million)

8.6.4 Market size, by test type, 2017 - 2030 (USD Million)

8.6.5 Market size, by end-use, 2017 - 2030 (USD Million)

8.6.6 South Africa

8.6.6.1 Market size, by components, 2017 - 2030 (USD Million)

8.6.6.2 Market size, by technique, 2017 - 2030 (USD Million)

8.6.6.3 Market size, by test type, 2017 - 2030 (USD Million)

8.6.6.4 Market size, by end-use, 2017 - 2030 (USD Million)

8.6.7 Saudi Arabia

8.6.7.1 Market size, by components, 2017 - 2030 (USD Million)

8.6.7.2 Market size, by technique, 2017 - 2030 (USD Million)

8.6.7.3 Market size, by test type, 2017 - 2030 (USD Million)

8.6.7.4 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 9 Company Profiles

9.1 Competitive dashboard, 2021

9.2 Grifols

9.2.1 Business Overview

9.2.2 Financial Data

9.2.3 Product Landscape

9.2.4 Strategic Outlook

9.2.5 SWOT Analysis

9.3 Ortho Clinical Diagnostics

9.3.1 Business Overview

9.3.2 Financial Data

9.3.3 Product Landscape

9.3.4 Strategic Outlook

9.3.5 SWOT Analysis

9.4 Immucor

9.4.1 Business Overview

9.4.2 Financial Data

9.4.3 Product Landscape

9.4.4 Strategic Outlook

9.4.5 SWOT Analysis

9.5 Quotient

9.5.1 Business Overview

9.5.2 Financial Data

9.5.3 Product Landscape

9.5.4 Strategic Outlook

9.5.5 SWOT Analysis

9.6 BAG GROUP DIAGNOSTICS

9.6.1 Business Overview

9.6.2 Financial Data

9.6.3 Product Landscape

9.6.4 Strategic Outlook

9.6.5 SWOT Analysis

9.7 Bio-Rad Laboratories

9.7.1 Business Overview

9.7.2 Financial Data

9.7.3 Product Landscape

9.7.4 Strategic Outlook

9.7.5 SWOT Analysis

9.8 Agena Biosciences Inc

9.8.1 Business Overview

9.8.2 Financial Data

9.8.3 Product Landscape

9.8.4 Strategic Outlook

9.8.5 SWOT Analysis

9.9 Thermo Fisher Scientific (One Lambda, Inc)

9.9.1 Business Overview

9.9.2 Financial Data

9.9.3 Product Landscape

9.9.4 Strategic Outlook

9.9.5 SWOT Analysis

9.10 Danaher (Beckman Coulter)

9.10.1 Business Overview

9.10.2 Financial Data

9.10.3 Product Landscape

9.10.4 Strategic Outlook

9.10.5 SWOT Analysis

9.11 Rapid Labs Ltd

9.11.1 Business Overview

9.11.2 Financial Data

9.11.3 Product Landscape

9.11.4 Strategic Outlook

9.11.5 SWOT Analysis

Authors: Mariam Faizullabhoy, Gauri Wani

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore Our Licensing Options:

Immediate Delivery Available

Premium Report Details

Base Year: 2021

Companies covered: 10

Tables & Figures: 234

Countries covered: 15

Pages: 165

Download Free PDF